Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026383

Options or other derivatives

  • Chief Communications Officer acquired 220,817 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ullerich Melissa Vera Chief Communications Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +6,979 6,979 D: show line 1 in the form
Ullerich Melissa Vera Chief Communications Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +58,161 58,161 D: show line 2 in the form
Ullerich Melissa Vera Chief Communications Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +104,689 104,689 D: show line 3 in the form
Ullerich Melissa Vera Chief Communications Officer 2021-10-22 Grant or award · Earnout Rights (Restricted Stock Units) +50,988 50,988 D: show line 4 in the form
Loading xslF345X03/ownership.xml…